Ataciguat

N/A

Report date: 2026/04/14 20:00:15
NME

Base Information

Drug NameAtaciguat
Drug Alias Name阿他昔夸阿他西呱HMR-1766
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSoluble guanylate cyclase stimulants
TargetsSoluble guanylate cyclase
Therapy Area/IndicationsPainIntermittent ClaudicationAortic Valve Stenosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[9
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesKardigan Inc
Active IndicationsAortic Valve Stenosis
Inactive IndicationsPainIntermittent Claudication

Other Information

ATC CodeN/A
Related LinksN/A